HPV vaccination of immunocompromised hosts

It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to na...

Descripción completa

Detalles Bibliográficos
Autores principales: Garland, S.M., Brotherton, J.M.L., Moscicki, A.B., Kaufmann, A.M., Stanley, M., Bhatla, N., Sankaranarayanan, R., de Sanjosé, S., Palefsky, J.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883202/
https://www.ncbi.nlm.nih.gov/pubmed/29179867
http://dx.doi.org/10.1016/j.pvr.2017.06.002
Descripción
Sumario:It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.

Ejemplares similares